Merck (MRK) Stops MK-7110 Development, Focuses on Molnupiravir

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Merck (MRK) Stops MK-7110 Development, Focuses on Molnupiravir

posted on Apr 19, 2021 09:08AM

https://finance.yahoo.com/news/merck-mrk-stops-mk-7110-141902470.html

"The company plans to start enrollment in the phase III portion of a phase II/III study in April or May to evaluate molnupiravir in outpatients (non-hospitalized patients) with COVID-19, based on promising data from the phase II portion. Final data from the phase III portion of the study are expected in September or October 2021."

Perhaps Apabetalone can beat Molnupiravir to the punch.

Koo

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply